Day

July 9, 2026
Aztreonam and Avibactam is an important combination used in the management of selected drug-resistant Gram-negative bacterial infections. By combining the antibacterial activity of Aztreonam with the beta-lactamase inhibition provided by Avibactam, this therapy helps address specific bacterial resistance mechanisms and supports targeted treatment in hospital and critical care settings. Antibiotic resistance is becoming one of...
Read More